000 01209 a2200325 4500
005 20250515062540.0
264 0 _c20070622
008 200706s 0 0 eng d
022 _a1462-8902
024 7 _a10.1111/j.1463-1326.2006.00665.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHermansen, K
245 0 0 _aDoes insulin detemir have a role in reducing risk of insulin-associated weight gain?
_h[electronic resource]
260 _bDiabetes, obesity & metabolism
_cMay 2007
300 _a209-17 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBlood Glucose
_xanalysis
650 0 4 _aDiabetes Mellitus
_xdrug therapy
650 0 4 _aDiabetes Mellitus, Type 1
_xdrug therapy
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadverse effects
650 0 4 _aInsulin
_xadverse effects
650 0 4 _aInsulin Detemir
650 0 4 _aInsulin, Long-Acting
650 0 4 _aWeight Gain
_xdrug effects
700 1 _aDavies, M
773 0 _tDiabetes, obesity & metabolism
_gvol. 9
_gno. 3
_gp. 209-17
856 4 0 _uhttps://doi.org/10.1111/j.1463-1326.2006.00665.x
_zAvailable from publisher's website
999 _c16945202
_d16945202